GRCL - Gracell Biotechnologies GAAP EPS of -$0.07 beats by $0.01
- Gracell Biotechnologies press release ( NASDAQ: GRCL ): Q3 GAAP EPS of -$0.07 beats by $0.01 .
- As of September 30, 2022, the Company had RMB1,629.6 million (US$229.1 million) in cash and cash equivalents and short-term investments.
For further details see:
Gracell Biotechnologies GAAP EPS of -$0.07 beats by $0.01